Drug Safety: Ingredient Origin and Government Purchases
This act aims to enhance drug supply chain security in the U.S. by tracking drug origins and limiting federal agencies' purchases of drugs from China. Citizens can expect greater transparency regarding drug ingredients and potentially increased availability of non-Chinese manufactured drugs in federal programs.
Key points
Requirement to label the country of origin for each active ingredient in drugs, increasing transparency for consumers.
Federal health programs (e.g., for veterans) will gradually limit the purchase of drugs with active ingredients from China, aiming to strengthen the domestic supply chain.
Companies manufacturing pharmaceuticals and medical devices in the U.S. may receive tax benefits, encouraging more domestic production.
Expired
Citizen Poll